MRI measures should be a primary outcome endpoint in Phase III randomized, controlled trials in multiple sclerosis: Yes
Journal article published in 2014 by
Maria Pia Sormani 
,
Nicola De Stefano
,
Nicola De Stefano
This paper was not found in any repository, but could be made available legally by the author.
Full text: Unavailable
Published version:
archiving forbidden
Data provided by 